4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-25-004947
CVP, JAPAC sold 330 shares at $74.42 ($24,560)
- CVP, JAPAC acquired 330 shares (option exercise)
- CVP, JAPAC acquired 4,225 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lippis Daniel J. · CVP, JAPAC
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-08 | Grant or award : show line 1 in the form 10b5-1 | +4,225 | 26,616.11 | D | ||
| 2025-05-09 | Exercise or conversion : show line 2 in the form 10b5-1 | +330 | $45.28 | $14,941 | 26,946.11 | D |
| 2025-05-09 | Sale : show line 3 in the form 10b5-1 | −330 | $74.42 | $24,560 | 26,616.11 | D |
| Open-market sales · 330 sh · avg $74.42 · $24,560 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-05-08 | Grant or award : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) | +21,500 | 21,500 | D |
| 2025-05-08 | Grant or award : show line 5 in the form 10b5-1 Performance Rights | +4,225 | 4,225 | D |
| 2025-05-09 | Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −330 | 0 | D |
Loading xslF345X05/doc4.xml…